Privia Health [PRVA] vs Ge Healthcare [GEHC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Privia Health Group Inc. wins in 7 metrics, Ge Healthcare Technologies Inc. wins in 13 metrics, with 0 ties. Ge Healthcare Technologies Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Privia Health Group Inc. | Ge Healthcare Technologies Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 133.78 | 15.92 | Ge Healthcare Technologies Inc. |
| Price-to-Book Ratio | 4.04 | 3.18 | Ge Healthcare Technologies Inc. |
| Debt-to-Equity Ratio | 1.21 | 98.72 | Privia Health Group Inc. |
| PEG Ratio | 1.78 | -0.87 | Privia Health Group Inc. |
| EV/EBITDA | 58.04 | 10.74 | Ge Healthcare Technologies Inc. |
| Profit Margin (TTM) | 1.08% | 10.10% | Ge Healthcare Technologies Inc. |
| Operating Margin (TTM) | 2.08% | 15.73% | Ge Healthcare Technologies Inc. |
| EBITDA Margin (TTM) | 2.08% | 15.73% | Ge Healthcare Technologies Inc. |
| Return on Equity | 4.03% | 22.38% | Ge Healthcare Technologies Inc. |
| Return on Assets (TTM) | 1.71% | 5.47% | Ge Healthcare Technologies Inc. |
| Free Cash Flow (TTM) | $163.40M | $1.51B | Ge Healthcare Technologies Inc. |
| Dividend Yield | N/A | 0.25% | N/A |
| 1-Year Return | -5.49% | -11.62% | Privia Health Group Inc. |
| Price-to-Sales Ratio (TTM) | 1.43 | 1.60 | Privia Health Group Inc. |
| Enterprise Value | $2.56B | $39.12B | Ge Healthcare Technologies Inc. |
| EV/Revenue Ratio | 1.21 | 1.90 | Privia Health Group Inc. |
| Gross Profit Margin (TTM) | 9.18% | 39.68% | Ge Healthcare Technologies Inc. |
| Revenue per Share (TTM) | $17 | $45 | Ge Healthcare Technologies Inc. |
| Earnings per Share (Diluted) | $0.18 | $4.55 | Ge Healthcare Technologies Inc. |
| Beta (Stock Volatility) | 0.87 | 1.31 | Privia Health Group Inc. |
| Short % of Float | 2.95% | 3.07% | Privia Health Group Inc. |
Privia Health Group Inc. vs Ge Healthcare Technologies Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Privia Health Group Inc. | 1.22% | 0.56% | -10.95% | -9.27% | -9.27% | -7.80% |
| Ge Healthcare Technologies Inc. | 1.35% | 3.74% | 5.95% | -16.13% | -24.33% | -21.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Privia Health Group Inc. | -5.49% | -13.41% | -35.31% | -40.78% | -40.78% | -40.78% |
| Ge Healthcare Technologies Inc. | -11.62% | -22.05% | 9.87% | 9.87% | 9.87% | 9.87% |
Performance & Financial Health Analysis: Privia Health Group Inc. vs Ge Healthcare Technologies Inc.
| Metric | PRVA | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $2.96B | $31.89B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 800,795 | 2,502,586 |
| 90 Day Avg. Volume | 837,622 | 3,405,145 |
| Last Close | $21.63 | $64.67 |
| 52 Week Range | $18.77 - $26.51 | $58.75 - $89.77 |
| % from 52W High | -18.41% | -27.96% |
| All-Time High | $50.77 (Jun 28, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -57.40% | -31.78% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.07% |
| Quarterly Earnings Growth | 1.08% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.10% |
| Operating Margin (TTM) | 0.02% | 0.16% |
| Return on Equity (TTM) | 0.04% | 0.22% |
| Debt to Equity (MRQ) | 1.21 | 98.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.96 | $22.77 |
| Cash per Share (MRQ) | $3.88 | $9.86 |
| Operating Cash Flow (TTM) | $163.40M | $1.99B |
| Levered Free Cash Flow (TTM) | $134.46M | $1.69B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.25% |
| Last 12-Month Dividend | $0.00 | $0.20 |
Valuation & Enterprise Metrics Analysis: Privia Health Group Inc. vs Ge Healthcare Technologies Inc.
| Metric | PRVA (Apr 22, 2026) | GEHC (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 133.78 | 15.92 |
| Forward P/E | 20.13 | 13.02 |
| PEG Ratio | 1.78 | -0.87 |
| Price to Sales (TTM) | 1.43 | 1.60 |
| Price to Book (MRQ) | 4.04 | 3.18 |
| Market Capitalization | ||
| Market Capitalization | $2.96B | $31.89B |
| Enterprise Value | $2.56B | $39.12B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.21 | 1.90 |
| Enterprise to EBITDA | 58.04 | 10.74 |
| Risk & Other Metrics | ||
| Beta | 0.87 | 1.31 |
| Book Value per Share (MRQ) | $5.96 | $22.77 |
Financial Statements Comparison: Privia Health Group Inc. vs Ge Healthcare Technologies Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PRVA (2025) | GEHC (2025) |
|---|---|---|
| Revenue/Sales | 2.12B | 20.63B |
| Cost of Goods Sold | 1.91B | 12.38B |
| COGS % of Revenue | 90.1% | 60.0% |
| Gross Profit | 209.43M | 8.25B |
| Gross Margin | 9.9% | 40.0% |
| Research & Development | N/A | 1.26B |
| Operating Income (EBIT) | 34.24M | 2.76B |
| Operating Margin | 1.6% | 13.4% |
| EBITDA | 44.14M | 3.69B |
| EBITDA Margin | 2.1% | 17.9% |
| Pre-Tax Income | 43.94M | 2.77B |
| Pre-Tax Income % of Revenue | 2.1% | 13.4% |
| Income Tax | 14.21M | 614.00M |
| Income Tax % of Revenue | 0.7% | 3.0% |
| Net Income (Profit) | 29.73M | 2.15B |
| Profit Margin | 1.4% | 10.4% |
Balance Sheet & Liquidity Metrics
| Metric | PRVA (2025) | GEHC (2025) |
|---|---|---|
| Cash & Equivalents | 479.69M | 4.49B |
| Total Current Assets | 911.00M | 12.50B |
| Total Current Assets % of Revenue | 42.9% | 60.6% |
| Total Current Liabilities | 568.52M | 9.11B |
| Total Current Liabilities % of Revenue | 26.8% | 44.1% |
| Long-Term Debt | 7.33M | 9.82B |
| Long-Term Debt % of Revenue | 0.3% | 47.6% |
| Total Shareholders Equity | 790.94M | 10.60B |
| Retained Earnings | -156.31M | 5.28B |
| Retained Earnings % of Revenue | -7.4% | 25.6% |
| Property, Plant & Equipment | 8.79M | 410.00M |
Cash Flow Statement Comparison
| Metric | PRVA (2025) | GEHC (2025) |
|---|---|---|
| Operating Cash Flow | 150.18M | 3.02B |
| Operating Cash Flow % of Revenue | 7.1% | 14.6% |
| Capital Expenditures | N/A | -482.00M |
| Free Cash Flow | 163.40M | 1.51B |
| FCF Margin | 7.7% | 7.3% |
| Debt Repayment | N/A | -1.77B |
| Common Stock Repurchase | N/A | -200.00M |
Short Interest & Institutional Ownership Analysis
| Metric | PRVA | GEHC |
|---|---|---|
| Shares Short | 2.48M | 12.36M |
| Short Ratio | 2.85 | 3.20 |
| Short % of Float | 2.95% | 3.07% |
| Shares Outstanding | 123.60M | 455.74M |
| Float Shares | 111.02M | 454.48M |
| % Held by Insiders | 6.38% | 0.35% |
| % Held by Institutions | 97.14% | 93.39% |
| % Held by Public | -3.52% | 6.26% |
Dividend Analysis & Yield Comparison: Privia Health Group Inc. vs Ge Healthcare Technologies Inc.
| Metric | PRVA | GEHC |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.20 |
| Last 12-Month Dividend Yield | N/A | 0.25% |
| 3-Year Avg Annual Dividend | $0.05 | $0.15 |
| 3-Year Avg Dividend Yield | 0.18% | 0.04% |
| 3-Year Total Dividends | $0.15 | $0.45 |
| Ex-Dividend Date | Mar 28, 2023 | Apr 02, 2026 |